Amrfy XL 0.25% Cream
By Amrfy
50gm Cream in a Tube

Composition
Amorolfine(0.25% w/w)

Manufacturer - Hegde and Hegde Pharmaceutical LLP
Office No. 11A – 15, 1st Floor, Free Press House, 215, Nariman Point, Mumbai – 400 021

Expires on or after
July, 2025

liver
In relation to liver issues, there is no interaction that has been found or established regarding the use of Amrfy XL 0.25% Cream. It is important to be cautious about any potential effects on the liver. Before using Amrfy XL 0.25% Cream, consulting with your doctor for proper guidance is recommended to ensure your safety.

kidney
No interaction with the kidney has been found or established regarding Amrfy XL 0.25% Cream. Consult with your doctor for proper guidance before using Amrfy XL 0.25% Cream.

alcohol
Currently, there is no information available regarding any interactions between alcohol and Amrfy XL 0.25% Cream. It is always important to consult with a healthcare provider if you have any concerns or questions about consuming alcohol while using Amrfy XL 0.25% Cream.

driving
No interaction found or established with Amrfy XL 0.25% Cream and driving. It is safe to drive while using Amrfy XL 0.25% Cream.

pregnancy
Information regarding the safety of using Amrfy XL 0.25% Cream during pregnancy is currently not available. It is recommended to consult with your healthcare provider before using this product.

breastfeeding
When using Amrfy XL 0.25% Cream, caution is advised during breastfeeding. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug is no longer present in her system.
Habit Forming | No |
Chemical Class | Phenylpropane Derivative |
Therapeutic Class | DERMA |
Action Class | Antifungal Others |
₹450
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024